Over the past two decades there has been a sharp rise in the number and severity of infections caused by the bacteria Clostridium difficile often shortened to C. diff now the most common hospital acquired infection in the ...
Feb 6, 2017
0
1
(HealthDay)—Use of fecal microbiota transplantation (FMT) is cost-effective for recurrent Clostridium difficile infection (CDI), according to a study published in the December issue of the Journal of Gastroenterology and ...
Dec 12, 2016
0
1
When associate professor of pharmacy practice Tadd Hellwig and three pharmacy colleagues at the Sanford USD Medical Center noticed that some hospital patients given two common antibiotics developed kidney failure, they decided ...
Dec 3, 2015
0
4
Results of a small Johns Hopkins Children's Center study show that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney ...
Dec 22, 2014
0
0
In an analysis of more than 8,000 episodes of Staphylococcus aureus bloodstream infections, there were no significant differences in the risk of death when comparing patients exhibiting less susceptibility to the antibiotic ...
Oct 9, 2014
0
0
A study published in today's New England Journal of Medicine reports that the antibiotic dalbavancin is as effective as vancomycin, the current standard-of-care antibiotic used to treat serious bacterial skin and skin-structure ...
Jun 4, 2014
0
1
(HealthDay)—For patients undergoing spinal procedures, the local application of vancomycin powder in surgical wounds does not significantly reduce the incidence of infection, according to a study published in the Dec. 1 ...
Dec 10, 2013
0
0
A drug approved just two years ago for treating bacterial infections may hold promise for treating the potentially fatal MRSA pneumonia, according to a Henry Ford Hospital study.
Sep 11, 2013
0
0
A plastic material already used in absorbable surgical sutures and other medical devices shows promise for continuous administration of antibiotics to patients with brain infections, scientists are reporting in a new study. ...
Aug 7, 2013
0
0
(HealthDay)—The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable.
Jun 24, 2013
0
0
